Auden Mckenzie (Pharma Division) Limited
Manufacture of basic pharmaceutical products · Castleford
ActiveUnited KingdomIncorporated 1999Private Limited Company
Financial position
Accounts to 2025-12-31 · GBP · Company accounts
Net assets
£34,187,000
Cash
—
Turnover
£3,409,000
Profit / loss
£14,613,000
Current assets
£39,865,000
Creditors < 1 year
£5,678,000
Equity
£34,187,000
Average employees
Not available
Balance-sheet trend
GBP · companyFinancial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
Some figures were read by AI from scanned accounts, so small errors are possible. View the filed accounts
| Reported figures | 2025-12-31Company · AI-read | 2024-12-31Company · AI-read |
|---|---|---|
| Balance sheet | ||
| Net assets | £34,187,000 | £70,799,000 |
| Equity | £34,187,000 | £70,799,000 |
| Share capital | £1,000 | £1,000 |
| Retained earnings | £34,186,000 | £70,798,000 |
| Assets | ||
| Current assets | £39,865,000 | £73,155,000 |
| Debtors | £39,865,000 | £73,155,000 |
| Liabilities | ||
| Creditors within one year | £5,678,000 | £2,356,000 |
| Net current assets | £34,187,000 | £70,799,000 |
| Assets less current liabilities | £34,187,000 | £70,799,000 |
| Profit & loss | ||
| Turnover | £3,409,000 | £2,676,000 |
| Gross profit | £3,409,000 | £2,676,000 |
| Other operating income | £14,887,000 | −£41,000 |
| Operating profit | £18,296,000 | £2,630,000 |
| Interest receivable | £1,190,000 | £1,099,000 |
| Interest payable | £2,000 | — |
| Profit before tax | £19,484,000 | £3,729,000 |
| Tax | £4,871,000 | £932,000 |
| Profit / loss | £14,613,000 | £2,797,000 |
| Dividends | £51,225,000,000 | — |
| Operating costs | ||
| Audit fees | £15,000,000 | £15,000,000 |
| Source evidence | View filing | View filing |
From the accounts
What the accounts for 2025-12-31 say about themselves, read by AI from the scanned filing.
- Auditor
- Azets Audit Services Limited
- Audit opinion
- Clean (unmodified)
- Immediate parent
- Auden McKenzie Holdings Limited
- Ultimate parent
- Teva Pharmaceutical Industries Limited
- Ultimate controlling party
- Teva Pharmaceutical Industries Limited
- Accounts
- FRS 102
- Approved
- 2026-09-11, signed by D Cooper
Turnover by segment (4)
- United Kingdom: 745 (000s) (2025-12-31)
- Europe: 2,664 (000s) (2025-12-31)
- United Kingdom: 952 (000s) (2024-12-31)
- Europe: 1,724 (000s) (2024-12-31)
Related parties (1)
- Auden McKenzie Holdings Limited · immediate parent company · dividend paid · £51,225,000
Share classes (1)
- 1,000 ordinary shares of £1
Events after the year end (1)
- On 9 June 2026, the entire share capital of the company was distributed by Auden McKenzie Holdings Limited and, through a series of further distributions, from this date the company's immediate parent undertaking changed to Actavis UK Group Limited.
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
0 outstanding chargesShow 3 satisfied / released
Floating · created 2007-01-31 · satisfied 2014-12-12
All monies
SatisfiedAll Assets · created 2007-01-23 · satisfied 2014-12-12
All monies
SatisfiedProperty · created 2003-01-03 · satisfied 2014-11-14
£6,250.00 DUE OR TO BECOME DUE FROM THE COMPANY TO THE CHARGEE
Satisfied